Ryoo BY - Search Results

1

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

Park YH, Lee JL, Ryoo BY, Ryu MH, Yang SH, Kim BS, Shin DB, Chang HM, Kim TW, Yuh YJ, Kang YK. Park YH, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 2008 Apr;61(4):623-9. doi: 10.1007/s00280-007-0515-7. Epub 2007 May 24. Cancer Chemother Pharmacol. 2008. PMID: 17522863 Clinical Trial.

2

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI. Ryoo BY, et al. Am J Clin Oncol. 1999 Jun;22(3):253-7. doi: 10.1097/00000421-199906000-00008. Am J Clin Oncol. 1999. PMID: 10362331 Clinical Trial.

3

A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer.

Kang YK, Ryoo BY, Kim TY, Im YH, Kim BS, Park YH, Lee CT. Kang YK, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 1999;44(6):518-21. doi: 10.1007/s002800051127. Cancer Chemother Pharmacol. 1999. PMID: 10550574 Clinical Trial.

4

Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study.

Choi SJ, Ryoo BY, Lee SS, Park Y, Kim BS, Kang YK. Choi SJ, et al. Among authors: ryoo by. Haematologica. 2002 May;87(5):555-7. Haematologica. 2002. PMID: 12010675 Clinical Trial. No abstract available.

5

Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.

Kang YK, Park YH, Ryoo BY, Bang YJ, Cho KS, Shin DB, Kim HC, Lee KH, Park YS, Lee KS, Heo DS, Kim SY, Cho EK, Lim HY, Kim WK, Lee JA, Kim TY, Lee JC, Yoon HJ, Kim NK. Kang YK, et al. Among authors: ryoo by. J Int Med Res. 2002 May-Jun;30(3):220-9. doi: 10.1177/147323000203000302. J Int Med Res. 2002. PMID: 12166338 Free article. Clinical Trial.

6

Primary malignant lymphoma of the breast: clinicopathological study of nine cases.

Park YH, Kim SH, Choi SJ, Ryoo BY, Kang YK, Lee SS. Park YH, et al. Among authors: ryoo by. Leuk Lymphoma. 2004 Feb;45(2):327-30. doi: 10.1080/10428190310001597892. Leuk Lymphoma. 2004. PMID: 15101719

7

Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

Park YH, Lee JC, Kim CH, Ryoo BY, Kim HT. Park YH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2004 May;34(5):245-9. doi: 10.1093/jjco/hyh043. Jpn J Clin Oncol. 2004. PMID: 15231858 Clinical Trial.

8

A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site.

Park YH, Ryoo BY, Choi SJ, Yang SH, Kim HT. Park YH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2004 Nov;34(11):681-5. doi: 10.1093/jjco/hyh124. Jpn J Clin Oncol. 2004. PMID: 15613558 Review.

9

PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.

Park YH, Choi SJ, Ryoo BY, Kim HT. Park YH, et al. Among authors: ryoo by. Clin Nucl Med. 2005 Feb;30(2):131-4. doi: 10.1097/00003072-200502000-00020. Clin Nucl Med. 2005. PMID: 15647689 No abstract available.

10

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC, Park K. Lee J, et al. Among authors: ryoo by. Eur J Cancer. 2005 Jul;41(10):1402-8. doi: 10.1016/j.ejca.2005.03.010. Eur J Cancer. 2005. PMID: 15963893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters